Perseon Corp Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2010-12-23: Form 8-K; Period of report 2010-12-20; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2010-12-14: Form 8-K; Period of report 2010-12-14; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2010-11-18: Form 8-K/A; Period of report 2010-11-17; Description 9.01 Financial Statements and Exhibits.
- 2010-11-15: Form 8-K; Period of report 2010-11-15; Description 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2010-12-23 | 8-K | 2010-12-20 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On December 20, 2010, BSD Medical Corporation, (the “Company”) received notification from Paul F. Turner requesting that he not be nominated for reelection as a Director of the Company at the Company’s next annual meeting of shareholders, which will be held on February 2, 2011. | bsdm8k20101220.htm |
| 2010-12-14 | 8-K | 2010-12-14 | 7.01 Regulation FD Disclosure | 7.01 On December 14, 2010, BSD Medical Corporation (the “Company”) issued a press release announcing success in the Company’s initial product launch for the MicroThermX Microwave Ablation System (MTX-180). | bsdm8k20101214.htm |
| 2010-11-18 | 8-K/A | 2010-11-17 | 9.01 Financial Statements and Exhibits | bsdm8ka20101117.htm | |
| 2010-11-15 | 8-K | 2010-11-15 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 The information set forth in Item 1.01 with respect to the Offering is hereby incorporated herein by reference. | bsdm8k20101115.htm |
| 2010-11-01 | 8-K | 2010-11-01 | 7.01 Regulation FD Disclosure | 7.01 On November 1, 2010, BSD Medical Corporation (the “Company”) issued a press release announcing that the Company has received CE (Conformite Europeenne) Mark approval for the commercial sale of the MicroThermX Microwave Ablation System in Europe. | bsdm8k20101101.htm |
| 2010-08-24 | 8-K/A | 2010-08-19 | 9.01 Financial Statements and Exhibits | bsdm8ka20100819.htm | |
| 2010-08-19 | 8-K | 2010-08-19 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 The information set forth in Item 1.01 with respect to the Offering is hereby incorporated herein by reference. | bsdm8k20100819.htm |
| 2010-08-18 | 8-K | 2010-08-18 | 7.01 Regulation FD Disclosure | 7.01 On August 18, 2010, BSD Medical Corporation (the “Company”) issued a press release announcing that the U.S. Food and Drug Administration has granted the Company a 510(k) clearance to market its MicroThermX Microwave Ablation System for ablation of soft tissue. | bsdm8k20100818.htm |
| 2010-05-05 | 8-K/A | 2010-05-03 | 9.01 Financial Statements and Exhibits | 9.01 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. | bsdm8ka120100503.htm |
| 2010-05-03 | 8-K | 2010-05-03 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 The information set forth in Item 1.01 with respect to the Offering is hereby incorporated herein by reference. | bsdm8k20100503.htm |
| 2010-02-17 | 8-K/A | 2010-02-11 | 9.01 Financial Statements and Exhibits | bsdm8ka20100211.htm | |
| 2010-02-11 | 8-K | 2010-02-11 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 The information set forth in Item 1.01 with respect to the Offering is hereby incorporated herein by reference. | bsd8k.htm |
| 2010-02-11 | 8-K | 2010-02-09 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 On February 10, 2010, the BSD Medical Corporation (the “Company”) issued a press release announcing that its Board of Directors (the “Board”) had formed a Corporate Governance and Nominating Committee comprised of the Board’s four independent directors: Timothy McQuay, Steven Stewart, Michael Nobel and Douglas Boyd. | bsdm8k20100209.htm |
| 2010-02-09 | 8-K | 2010-02-03 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 At the annual meeting of stockholders of BSD Medical Corporation (the “Company”) held on February 3, 2010 (the “Annual Meeting”), the stockholders approved an amendment and restatement (the “Director Plan Amendment”) to the Company’s Third Amended and Restated 1998 Director Stock Plan (such plan, as amended, the “Director Stock Plan”). | bsdm8k20100203.htm |